Status:
COMPLETED
Improving Multivitamin Supplementation to Pregnant Women
Lead Sponsor:
The Hospital for Sick Children
Collaborating Sponsors:
Duchesnay Inc.
Conditions:
Pregnancy
Morning Sickness
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the tolerability of Pregvit® to a common prenatal vitamin (Orifer® F) among pregnant women with morning sickness or those suffering from a variety of conditions...
Detailed Description
Presently, there is a large choice of perinatal vitamins on the market. Materna® is taken by 70% of Canadian women. A recent study by the investigators team has shown that up to 35%-53% of women with ...
Eligibility Criteria
Inclusion
- Any woman who discontinued her standard vitamins due to gastrointestinal symptoms or due to the tablet size, with one ofthe following conditions:
- Morning sickness.
- Gastrointestinal disorders: Crohn's disease, ulcerative colitis, peptic or duodenal ulcer, irritable colon, celiac disease.
- Iron deficiency anemia.
- Hypothyroidism.
- Depression.
Exclusion
- Women who do not agree to consent to this protocol.
- Women with a known hypersensitivity to any of the ingredients of Pregvit®, or Orifer® F.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
1370 Patients enrolled
Trial Details
Trial ID
NCT02300155
Start Date
October 1 2004
End Date
January 1 2008
Last Update
November 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G 1X8